PT98215A - Processo para a preparacao de citrato de 2-hidroxi-1,2,3-propanotricarboxilato de 3-{(5-metil-2-furanil)metil}-n-(4-piperidinil)-3h-imidazo-{4,5-b}piridin-2-amina e de composicoes farmaceuticas que o contem - Google Patents

Processo para a preparacao de citrato de 2-hidroxi-1,2,3-propanotricarboxilato de 3-{(5-metil-2-furanil)metil}-n-(4-piperidinil)-3h-imidazo-{4,5-b}piridin-2-amina e de composicoes farmaceuticas que o contem

Info

Publication number
PT98215A
PT98215A PT98215A PT9821591A PT98215A PT 98215 A PT98215 A PT 98215A PT 98215 A PT98215 A PT 98215A PT 9821591 A PT9821591 A PT 9821591A PT 98215 A PT98215 A PT 98215A
Authority
PT
Portugal
Prior art keywords
methyl
imidazo
furanyl
piperidinyl
pyridin
Prior art date
Application number
PT98215A
Other languages
English (en)
Other versions
PT98215B (pt
Inventor
Alfons Gaston Maria De Knaep
Tonny Franciscus Johanna Nelen
Frans Eduard Janssens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PT98215A publication Critical patent/PT98215A/pt
Publication of PT98215B publication Critical patent/PT98215B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicinal Preparation (AREA)
  • Furan Compounds (AREA)
PT98215A 1990-07-06 1991-07-04 Processo para a preparacao de citrato de 2-hidroxi-1,2,3-propanotricarboxilato de 3-{(5-metil-2-furanil)metil}-n-(4-piperidinil)-3h-imidazo-{4,5-b}piridin-2-amina e de composicoes farmaceuticas que o contem PT98215B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54935090A 1990-07-06 1990-07-06

Publications (2)

Publication Number Publication Date
PT98215A true PT98215A (pt) 1992-06-30
PT98215B PT98215B (pt) 1999-01-29

Family

ID=24192647

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98215A PT98215B (pt) 1990-07-06 1991-07-04 Processo para a preparacao de citrato de 2-hidroxi-1,2,3-propanotricarboxilato de 3-{(5-metil-2-furanil)metil}-n-(4-piperidinil)-3h-imidazo-{4,5-b}piridin-2-amina e de composicoes farmaceuticas que o contem

Country Status (25)

Country Link
EP (1) EP0464927B1 (pt)
JP (1) JPH04230382A (pt)
KR (1) KR0165894B1 (pt)
CN (1) CN1026790C (pt)
AT (1) ATE142207T1 (pt)
AU (1) AU632949B2 (pt)
BG (1) BG60067B2 (pt)
CA (1) CA2043564A1 (pt)
CZ (1) CZ279435B6 (pt)
DE (1) DE69121807T2 (pt)
ES (1) ES2091285T3 (pt)
FI (1) FI94132C (pt)
GR (1) GR3020951T3 (pt)
HU (1) HUT58333A (pt)
IE (1) IE75695B1 (pt)
IL (1) IL98725A (pt)
MX (1) MX9100102A (pt)
NO (1) NO177854C (pt)
NZ (1) NZ238369A (pt)
PL (1) PL168719B1 (pt)
PT (1) PT98215B (pt)
RU (1) RU2047615C1 (pt)
SG (1) SG48825A1 (pt)
SK (1) SK278127B6 (pt)
ZA (1) ZA915241B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6211199B1 (en) 1995-11-17 2001-04-03 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
US6194406B1 (en) 1995-12-20 2001-02-27 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease
US6423704B2 (en) 1995-12-20 2002-07-23 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
US5998439A (en) * 1996-02-21 1999-12-07 Hoescht Marion Roussel, Inc. Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
US5922737A (en) * 1996-02-21 1999-07-13 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
US5932571A (en) * 1996-02-21 1999-08-03 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) {1,4}diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases
KR100289063B1 (ko) * 1997-12-17 2001-05-02 정선종 누름스윗치에의한휴대전화기용자동안테나

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0144101B1 (en) * 1983-11-30 1991-02-06 Janssen Pharmaceutica N.V. Bicyclic heterocyclyl containing n-(bicyclic heterocyclyl)-4-piperidinamines
EG17993A (en) * 1986-02-03 1991-08-30 Janssen Pharmaceutica Nv Anti-histaminic compositions containing n-heterocyclyl-4-piperidinanines
GB8900380D0 (en) * 1989-01-09 1989-03-08 Janssen Pharmaceutica Nv 2-aminopyrimidinone derivatives
PH30434A (en) * 1989-04-07 1997-05-09 Janssen Pharmaceutica Nv Hydroxyalkylfuranyl derivatives

Also Published As

Publication number Publication date
CS198791A3 (en) 1992-03-18
MX9100102A (es) 1992-02-28
PL168719B1 (pl) 1996-03-29
FI913281A0 (fi) 1991-07-05
DE69121807T2 (de) 1997-01-23
NO177854C (no) 1995-12-06
RU2047615C1 (ru) 1995-11-10
CZ279435B6 (cs) 1995-04-12
KR920002597A (ko) 1992-02-28
DE69121807D1 (de) 1996-10-10
AU8020691A (en) 1992-01-09
CN1026790C (zh) 1994-11-30
ZA915241B (en) 1993-03-31
FI94132B (fi) 1995-04-13
EP0464927A3 (en) 1992-04-08
SK278127B6 (en) 1996-02-07
IE912362A1 (en) 1992-01-15
AU632949B2 (en) 1993-01-14
PL290956A1 (en) 1992-06-26
IL98725A0 (en) 1992-07-15
CN1058020A (zh) 1992-01-22
BG60067B2 (bg) 1993-09-30
IE75695B1 (en) 1997-09-10
ES2091285T3 (es) 1996-11-01
JPH04230382A (ja) 1992-08-19
PT98215B (pt) 1999-01-29
ATE142207T1 (de) 1996-09-15
NZ238369A (en) 1993-07-27
HUT58333A (en) 1992-02-28
NO912650D0 (no) 1991-07-05
NO177854B (no) 1995-08-28
EP0464927A2 (en) 1992-01-08
IL98725A (en) 1995-07-31
CA2043564A1 (en) 1992-01-07
GR3020951T3 (en) 1996-12-31
EP0464927B1 (en) 1996-09-04
NO912650L (no) 1992-01-07
FI94132C (fi) 1995-07-25
KR0165894B1 (ko) 1999-01-15
FI913281A (fi) 1992-01-07
HU912284D0 (en) 1991-12-30
SG48825A1 (en) 1998-05-18

Similar Documents

Publication Publication Date Title
DK0495982T3 (da) Bicyklisk pyrimidinderivat, fremgangsmåde til fremstilling deraf og farmaceutisk præparat omfattende dette som en aktiv bestanddel
MX9200817A (es) Derivados de piranil cianoguanidina y proceso para su preparacion.
ATE127463T1 (de) Verfahren und zwischenprodukte für die herstellung von verbindungen mit einem disubstituierten acetylenischem teil und mit biologischer, retinsäure-ähnlicher wirkung.
HU9801934D0 (en) Process for producing of herbicidal activity substituted aryl-halogenalkyl-pyrazol derivatives
MA21778A1 (fr) Procede d'obtention de derives de n - ( 3-hydroxy-4 piperidinyl ) dihydro-benzofuranne, dihydro-2h- ,benzopyranne ou dihydro benzodioxin ) carboxamide .
DK543787A (da) Naphthyridin-, quinolin- og benzoxazincarboxylsyreforbindelser med antibakteriel aktivitet
ATE233250T1 (de) Saccharinderivate als proteolytische enzyminhibitoren
PT98215A (pt) Processo para a preparacao de citrato de 2-hidroxi-1,2,3-propanotricarboxilato de 3-{(5-metil-2-furanil)metil}-n-(4-piperidinil)-3h-imidazo-{4,5-b}piridin-2-amina e de composicoes farmaceuticas que o contem
ES2147749T3 (es) Procedimiento para la preparacion de derivados de ciano-metoxiiminometilo.
ATE122042T1 (de) Pyrazoloisoquinoline-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
DK126982A (da) Fremgangsmaade til fremstilling af bis-estere af 1,1-alkandioler med 6beta-hydroxymethyl-penicillansyre-1,1-dioxid og en 6beta-acylaminopenicillansyre eller farmaceutisk acceptable salte deraf
HUT67695A (en) 4-[(2-benzothiazolyl)-methylamino]-alpha-[(3,4-difluorophenoxy)methyl]-1-piperedineethanol, pharmaceutical compositions containing that and process for preparing them
ATE303354T1 (de) Substanzen, welche apoptose einleiten können
ATE178328T1 (de) Loracarbef isopropanolat und umwandlungsverfahren vom isopropanolat in loracarbef monohydrat
NO996179D0 (no) Nye 1,2-ditiolanforbindelser, en fremgangsmåte for deres fremstilling og farmasoeytiske blandinger inneholdende disse
HUT42280A (en) Fungicidal compositions and process for preparing piperazinyl-methyl-1,2,4-triazolyl-methyl-carbinol derivatives applicable as active substance
HUT58327A (en) Process for produicng new heterocyclic-(oxazol)- derivatives and pharmaceutical compositions containing them
ATE246182T1 (de) Verfahren zur herstellung von 1,4-benzodioxan- derivaten
DE69401163D1 (de) Umwandlungsverfahren von Lorabef Dihydrate in Loracarbef Monohydrate
ATE122352T1 (de) 3-(3-ethyl-1,2,4-oxadiazol-5-yl)-1- azabicycloheptan, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zubereitungen.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920304

FG3A Patent granted, date of granting

Effective date: 19981001

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20020430